Product Authorization
Which products, which areas, which providers — set out per treatment rather than in general terms.
Toxins, fillers and biostimulators are the core of most aesthetic practices — and the category boards look at first. Direction, delegation and competency records are the whole game.
Each of these is a decision your director owns, in writing, before it happens in your clinic.
Which products, which areas, which providers — set out per treatment rather than in general terms.
Training sign-off per injector, refreshed as your team changes.
Vascular occlusion and adverse-event protocols with reversal agents on hand.
Who assesses the patient before treatment, and how that is documented.
Injectable programs need product-level authorization, injector competency on file, and complication protocols that are actually rehearsed.
Standing orders by product and treatment area
Injector competency sign-off per provider and device
Complication protocols, including hyaluronidase access
Clearance screening and consultation policy
Consent, photography and documentation standards
Adverse-event reporting and escalation route
Still not sure? Twenty minutes on the phone answers what a page can't.
Almost never. Scope is set by state license and delegation rules — your standing orders will say exactly who may inject what.
Presence and availability requirements vary by state and service. We confirm yours and write it into the agreement.
Your protocol names the steps, the reversal agents to keep stocked and who to call — before it happens, not after.
Product-specific. A general "injectables" authorization does not tell a board which provider is cleared for which product in which area — standing orders spell that out by name.
Per provider and per device, refreshed when someone joins or a new product is added — not a single sign-off from onboarding that never gets revisited.
Can a non-physician own a med spa that injects? The business, yes. The clinical entity, in most states no. Toxins and fillers are prescription medical treatment, and this is the category boards examine first.
That is what the corporate practice of medicine doctrine decides — and it is the single rule that shapes how your business is built. Most states hold that medical judgment belongs to licensed clinicians, so a non-physician or a general corporation may not own or control an entity that practices medicine. The MSO model is the answer the industry settled on.
A doctrine in state law, not a company or a service. The professional entity — the PC — must be owned by a licensed physician, and control counts as much as ownership: who hires the clinicians, who sets the fees, who decides what gets treated.
The company that provides everything a Injectables clinic needs that is not the practice of medicine, under a written management services agreement with the PC. You can own the MSO outright, whatever your license.
How the two meet: a physician-owned PC employs the clinical team and holds the medical decisions; your MSO holds the brand, the lease, the staff, the systems and the supply; a fair-market management fee moves between them; and the line is drawn in writing where your state says it must be. Delegation and competency records matter as much as the ownership diagram here.
How money actually moves through a PC/MSO structure — patient revenue landing in the PC, the fixed management transfer to the MSO, MedGrid's retainer, and physician compensation — the same CPOM flow of funds covered on this page, walked through step by step.
This isn't just how we recommend running the accounts. In a state that enforces corporate practice of medicine, this exact flow is required to keep a PC structure compliant: revenue lands in the PC first, the MSO is paid a fixed, fair-market amount rather than a share of medical revenue, MedGrid is paid a fixed retainer by the MSO, and the accounts stay separate.
It's also why MedGrid only builds on a PC — never a PLLC — in every state we work in. A PLLC lets revenue flow straight into a member's account with no equivalent separation, which is exactly the structure this flow of funds is built to avoid. Why that distinction matters.
These are the arrangements we most often find in place when a clinic comes to us, usually built in good faith, on advice from someone who had not read the state's rules.
The clinical entity was formed as a plain LLC owned by a non-physician. In a strict state that is the whole problem, and it usually surfaces at diligence or renewal.
A physician agreed to "be the medical director" with no management agreement, no delegation document and no standing orders. There is nothing to show a board.
The MSO takes a percentage of clinical revenue. Many states read that as fee-splitting regardless of what the contract calls it.
Treatment protocols copied from a training weekend, never adapted to this state or signed by the director who is supposed to own them.
General information about how these structures work, not legal advice for your clinic. Your director and your counsel confirm the specifics before you treat.
Twenty minutes tells you what direction costs in your state, what has to be on file before the first patient, and how fast you can start.